• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • NORTH AMERICA EDITION
      Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • NORTH AMERICA EDITION
      North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Market Market
    Market News
    Market Stocks
    • Market Market
    • Market News
    • Market Stocks

    Organigram Seeks Acquisition of Stake in German Cannabis Venture

    Bryan Mc Govern
    Oct. 17, 2018 08:52AM PST
    Market News

    Organigram Holdings announced its subsidiary executed an agreement with Alpha-Cannabis Germany to acquire stake in the capital of the company.

    Organigram Holdings (TSXV:OGI) announced its subsidiary executed an agreement with Alpha-Cannabis Germany to acquire stake in the capital of the company.

    As quoted in the press release:

    Organigram Holdings, a leading licensed producer of medical marijuana, is pleased to announce that it has, through its wholly-owned subsidiary 10870277 Canada, executed an investment agreement dated as of October 10, 2018 with alpha-cannabis Pharma GmbH pursuant to which the Purchaser will acquire 8,333 common shares of ACG, representing a 25 [percent] stake in the capital of ACG, for aggregate proceeds of €1,625,000.  The closing is subject to certain formalities under German law largely of an administrative nature.

    As part of the investment and effective upon the closing of the investment, OGI’s wholly-owned subsidiary, Organigram Inc. will enter into two supply agreements with ACG: one for the supply of cannabidiol isolate from ACG to Organigram Inc., and the other for the supply of dried cannabis flower from Organigram Inc. to ACG. In addition, ACG and Organigram Inc. will enter into an agreement pursuant to which the companies will jointly evaluate and bid on certain licenses to supply medical cannabis to the German market.

    Click here to read the full press release.

    Source: www.newswire.ca

    canadagermany
    The Conversation (0)

    Go Deeper

    AI Powered
    Cannabis Investing

    Cannabis Big News Roundup: CanadaBis Capital Acquires Retail Location; Lifestyle Delivery Systems Inc. to Amalgamate with TransCanna; BevCanna Awarded Health Canada Industrial Hemp Cultivation License

    Cannabis Investing

    Cannabis Weekly Round-Up: Quarterly Updates Rock Market

    Latest News

    Apple debuts iPhone 17

    Introducing iPhone Air, a powerful new iPhone with a breakthrough design

    Apple unveils iPhone 17 Pro and iPhone 17 Pro Max, the most powerful and advanced Pro models ever

    More News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×